Driven by its own experiences and a desire to improve lives, the University of Cincinnati VentureLab-backed startup is developing explainable artificial intelligence to more accurately diagnose women’s risk of coronary artery disease.
“Our explainable AI for diagnosing coronary artery disease risk will immediately help many women live longer, more fulfilling lives,” Martis said. It is done as part of an annual or biennial mammogram, without the need for additional images and fitting seamlessly into existing workflows, allowing individuals to receive two preventive diagnostics from their mammogram at no cost to them. [additional] Cost savings that bring true health equity and democratization.”
Prior to founding Genexia, Cohen and Satyan worked on developing explainable, trustworthy AI for applications in industries including healthcare, manufacturing, aerospace and financial technology.
Cohen and Sathyan enrolled together at the University of California’s Venture Lab to learn how to turn their ideas into viable products.
“We didn’t have the training, knowledge or experience to start a company,” said Cohen, director of Digital Futures’ AI Bio Lab and the Brian H. Rowe Endowed Professor of Aerospace Engineering in UC’s School of Engineering and Applied Science. “We wouldn’t have gotten to this stage without the Venture Lab process and Dino’s expertise in starting and scaling healthcare companies.”
UC’s Venture Lab provides a springboard for entrepreneurs to turn their ideas into reality. The lab is located in the Cincinnati Innovation District’s 1819 Innovation Hub and provides a connection point to talent, support and capital.
Venture Lab’s pre-accelerator program is free and available to all members of the university community. The seven-week program provides guidance on launching a startup and mentors aspiring entrepreneurs with executives.
